OWPC · XBRL financial data

One World Products financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (OWPC's year ends in late December)

In thousands of dollars	FY 2019Dec 31, 2019	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024
Revenue from contracts with customers	—	60	38	126	8	5
Cost of goods and services sold	—	105	20	301	173	1
Gross profit	—	(45)	19	(175)	(166)	4
General and administrative	2,245	3,961	2,294	1,587	1,290	654
Total operating expenses	5,821	7,872	3,250	2,061	1,915	1,876
Operating income (loss)	(5,821)	(7,918)	(3,231)	(2,236)	(2,081)	(1,872)
Interest income	—	—	2	0	0	—
Interest expense	383	48	511	957	309	1,094
Other income (expense)	(387)	(48)	—	—	—	—
Net income (loss)	(6,207)	(7,965)	(3,785)	(3,059)	(3,953)	(3,935)
Earnings per share, basic USD per share	—	—	(0.06)	(0.05)	(0.05)	(0.04)
Earnings per share, diluted USD per share	—	—	—	(0.05)	(0.05)	(0.04)
Weighted average shares, basic thousands of shares	—	—	60,601	66,192	73,335	106,971
Weighted average shares, diluted thousands of shares	—	—	—	66,192	73,335	106,971

Fiscal years (OWPC's year ends in late December)

In thousands of dollars	FY 2019Dec 31, 2019	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024
Cash and cash equivalents	282	29	120	11	1	42
Accounts receivable	—	6	20	12	—	0
Inventory	25	267	199	54	—	16
Total current assets	574	421	644	123	14	68
Property and equipment, net	698	727	1,003	989	—	—
Right-of-use asset	503	195	—	426	—	—
Total assets	1,847	1,408	2,903	3,168	99	68
Accounts payable	331	735	480	798	529	594
Accrued liabilities	110	551	458	948	939	651
Total current liabilities	1,133	1,702	1,524	2,977	3,872	3,169
Lease liability, non-current	453	156	—	342	—	—
Total liabilities	1,586	1,859	1,724	4,219	3,872	5,255
Accumulated deficit	(8,167)	(16,132)	(19,917)	(22,976)	(26,930)	(30,865)
Total stockholders' equity	261	(1,953)	(3,050)	(5,836)	(8,348)	(9,912)
Total liabilities and equity	1,847	1,408	2,903	3,168	99	68
Common shares outstanding (cover page) thousands of shares	45,710	61,335	65,862	70,203	104,330	109,226

Fiscal years (OWPC's year ends in late December)

In thousands of dollars	FY 2019Dec 31, 2019	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024
Net income (loss)	(6,207)	(7,965)	(3,785)	(3,059)	(3,953)	(3,935)
Stock-based compensation	237	3,579	134	339	—	—
Depreciation and amortization	20	34	40	42	34	0
Net cash from operating activities	(4,061)	(1,429)	(3,729)	(1,380)	(1,194)	(1,122)
Purchases of property and equipment	365	63	393	43	5	—
Net cash from investing activities	(467)	(63)	(388)	(37)	(5)	(75)
Proceeds from issuing common stock	4,380	1,577	3,578	350	650	150
Net cash from financing activities	4,697	1,275	4,219	1,318	1,060	1,281
Net change in cash	157	(253)	91	(109)	(10)	42

SIC 2834 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2834 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
One World Products	169	50	(145)*	120.1M	1.2 quarters	Q3 FY25 10-QSep 30, 2025
Regen BioPharma	0.2	59	(24)*	1.7B	0.0 quarters	Q3 FY26 10-QJun 30, 2026
Zivo Bioscience	57	66	(267)*	3.9M	0.2 quarters	Q3 FY25 10-QSep 30, 2025
Nutra Pharma	not reported	34	(251)*	7.2B	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Vyome Holdings	7,888	27	(904)*	7.0M	8.7 quarters	Q2 FY26 10-QJun 30, 2026
America Great Health	29	26	1.7*	21.2B	—	Q3 FY26 10-QMar 31, 2026
AIM ImmunoTech	9,900	26	(4,590)*	30.4M	2.2 quarters	Q2 FY26 10-QJun 30, 2026
Yarrow Bioscience	22,925	97	(1,992)*	2.7M	11.5 quarters	Q2 FY26 10-QJun 30, 2026
Cardiff Oncology	9,197	104	(11,765)*	77.8M	2.9 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.